NewsABH Healthcare IPO Day 2 Live: Total hits 1.04x; Retail jumps 27% - Check analysts view and moreABH Healthcare IPO Day 2 Live: Total hits 1.04x; Retail jumps 27% - Check analysts view and more
- ABH Healthcare IPO reached 1.04x subscription on Day 2, achieving full subscription.
- Retail category surged 27.4% intra-day, rising from 0.73x to 0.93x.
- QIB subscription remained steady at 8.37x throughout the day.
- Total equity grew from ₹6.35 crores in FY24 to ₹17.34 crores in FY26.
- Issue closes on 2026-08-27 with listing scheduled for 2026-09-01.
*this image is generated using AI for illustrative purposes only.
ABH Healthcare’s public issue closed with a total subscription of 1.47x. QIBs led the demand at 8.37x, while Retail investors subscribed 1.65x. The hospital chain’s shares are set to list on September 1, 2026.
Final Subscription Status
The issue saw robust institutional interest, with QIBs accounting for the bulk of the oversubscription. Retail participation crossed the 1x mark by the final day, ticking up significantly in the last hours. NII (bHNI) jumped +145.5% today (from 0.22x to 0.54x), while Retail jumped +47.3% today (from 1.12x to 1.65x).
| Day | Date | QIB | NII (bHNI) | NII (sHNI) | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 | 24-08-2026 | 3.45x | 0.07x | 0.01x | 0.31x | 0.37x |
| Day 2 | 25-08-2026 | 8.37x | 0.13x | 0.18x | 0.62x | 0.88x |
| Day 3 | 26-08-2026 | 8.37x | 0.16x | 0.20x | 0.93x | 1.04x |
| Day 4 | 27-08-2026 | 8.37x | 0.54x | 0.32x | 1.65x | 1.47x |
Intra-day timeline on 27-08-2026
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 11:15 | 8.37x | 0.22x | 1.12x | 1.14x |
| 12:15 | 8.37x | 0.30x | 1.23x | 1.20x |
| 13:15 | 8.37x | 0.37x | 1.35x | 1.28x |
| 14:15 | 8.37x | 0.42x | 1.46x | 1.36x |
| 15:15 | 8.37x | 0.49x | 1.54x | 1.41x |
| 16:15 | 8.37x | 0.54x | 1.65x | 1.47x |
Category-wise Breakdown
- QIB: 8.37x (Leading category)
- NII (bHNI): 0.54x
- NII (sHNI): 0.32x
- Retail: 1.65x
- Employees: 0x
About the Company
ABH Healthcare Limited operates a 150-bed multi-specialty tertiary care hospital under the "Anil Baghi Hospital" brand in Ferozepur, Punjab. Founded in 2021, the company acquired the business of M/s. Anil Baghi Hospital in 2022. It offers services across 25 medical specialties, including cardiac sciences and neurology, led by U.S.-trained doctors.
Financial Highlights
The company has shown consistent growth in revenue and profit over the last three fiscal years.
| Metric (₹ crores) | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|
| Revenue from Operations | 41.38 | 49.27 | 52.51 |
| Total Profit (PAT) | 1.66 | 5.35 | 5.64 |
| Total Equity | 6.35 | 11.69 | 17.34 |
Revenue grew from ₹41.38 crores in FY 2024 to ₹52.51 crores in FY 2026. Profit after tax increased significantly from ₹1.66 crores to ₹5.64 crores in the same period.
Objects of the Issue
- Repayment/prepayment of certain borrowings: ₹17.00 crores
- Funding working capital requirements: ₹5.00 crores
- Funding inorganic growth through unidentified acquisitions and general corporate purposes
Risk Factors
- Limited operating history as a company since incorporation in March 2021.
- Geographic revenue concentration risk with 100% revenue from its Ferozepur location.
- High debt-to-equity ratio of 3.20 in Fiscal 2026.
What's Next
Allotment is expected on August 28, 2026. The shares will list on NSE and BSE on September 1, 2026. The basis of allotment will be determined by the Registrar to the Issue.
How might the high debt-to-equity ratio of 3.20 impact ABH Healthcare's ability to execute its planned inorganic growth and acquisitions post-listing?
Given that 100% of revenue is derived from a single facility in Ferozepur, what specific expansion strategies does management have to mitigate geographic concentration risk?
Will the sharp late-day retail subscription surge indicate strong grassroots demand for healthcare stocks, or is it likely to lead to significant listing gains followed by profit-booking pressure?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
